• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Aemetis Inc. (DE)

    3/16/26 8:12:32 AM ET
    $AMTX
    Major Chemicals
    Industrials
    Get the next $AMTX alert in real time by email
    S-8 1 amtx20260206_s8.htm FORM S-8 amtx20260206_s8.htm

    As filed with the Securities and Exchange Commission on March 16, 2026.

    Registration No. 333-

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM S-8

     

    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

     

    Aemetis, Inc.

    (Exact name of registrant as specified in its charter)

     

    20400 Stevens Creek Blvd., Suite 700,

    Cupertino, California 95014

    (408) 213-0940

    (Address and telephone number of Principal Executive Office)

     

    Delaware

    26-1407544

    (State of Incorporation)

    (I.R.S. Employer Identification No.)

     

     

    Aemetis, Inc. Amended and Restated 2019 Stock Plan

    (Full title of the plan)

     

    J. Michael Rockett

    Executive Vice President, General Counsel,

    and Corporate Secretary

    Aemetis, Inc.

    20400 Stevens Creek Blvd., Suite 700

    Cupertino, CA 95014

    (408) 213-0940

    (Name, address, and telephone number of agent for service)

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

     

    Large accelerated filer  ☐

    Accelerated filer  ☒ 

    Non-accelerated filer  ☐

    Smaller reporting company  ☒

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     

     

    EXPLANATORY NOTE

     

    REGISTRATION OF ADDITIONAL SHARES

     

    This Registration Statement on Form S-8 is filed by Aemetis, Inc. (the “Registrant”) pursuant to General Instruction E to Form S-8 for the purpose of registering an additional 2,749,217 shares of the Registrant’s common stock, $0.001 par value per share (the “Common Stock”) authorized to be issued under the Aemetis, Inc. Amended and Restated 2019 Stock Plan (the “2019 Plan”).

     

    In accordance with General Instruction E to Form S-8, the contents of the Registrant’s Registration Statements on Form S-8 (File Nos. 333-285837, 333-278384, 333-270388, 333-263452, 333-254267, 333-248489, and 333-237101) filed with the Securities and Exchange Commission (the "Commission") on March 14, 2025, March 24, 2024, March 9, 2023, March 10, 2022, March 14, 2021, August 28, 2020, and March 12, 2020, respectively, are incorporated herein by reference and made part of this Registration Statement on Form S-8, except to the extent supplemented, superseded or modified herein.

     

    PART II

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 3. Incorporation of Documents by Reference.

     

    The following documents previously filed by the Registrant with the Commission are incorporated by reference in this Registration Statement:

     

    (a) The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Commission on March 16, 2026, which includes audited financial statements for the Registrant’s latest fiscal year;

     

    (b) All other reports filed by the Registrant pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), since the end of the fiscal year covered by the annual report described in (a) above; and

     

    (c) The description of the Registrant’s common stock, par value $0.001 per share, contained in the Registrant’s Form 8-A filed with the Commission on June 3, 2014, as amended by the Amendment No. 1 to Form 8-A filed with the Commission on November 10, 2021, as further updated by the Description of Capital Stock filed as Exhibit 99.1 to the Registrant's Current Report on Form 8-K filed with the Commission on February 19, 2026, and any other amendment or report filed for the purpose of updating such description.

     

    All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior to the filing of a post-effective amendment to this Registration Statement which indicates that all of the shares of Common Stock offered have been sold or which deregisters all of such shares then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of the filing of such documents, except as to any portion of any future annual or quarterly report to stockholders or document that is not deemed filed under such provisions.

     

    For purposes of this Registration Statement, any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

     

    Item 8. Exhibits.

     

    Exhibit Number

     

    Description of Exhibit

         

    4.1

     

    Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on November 2, 2021)

    4.2

     

    Bylaws of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 30, 2023)

    4.3   Certificate of Amendment to the Certificate of Incorporation of the Registrant (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 19, 2026)

    5.1 *

     

    Opinion of Willkie Farr & Gallagher LLP regarding the legality of the securities being registered

    23.1 *

     

    Consent of Independent Registered Public Accounting Firm
    23.2 *   Consent of Willkie Farr & Gallagher LLP (included in Exhibit 5.1)
    24 *   Power of Attorney (included on the signature page included in this Part II)

    99.1

     

    Aemetis, Inc. Amended and Restated 2019 Stock Plan (incorporated by reference to Appendix A to the Registrant’s Definitive Proxy Statement for the 2021 Annual Meeting of Stockholders, filed with the Securities and Exchange Commission on July 23, 2021)

    107 *

     

    Filing Fee Table

     

    * Filed herewith

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cupertino, State of California on March 13, 2026.

     

     

    Aemetis, Inc.

         
     

    By:  

    /s/ Eric A. McAfee

       

    Eric A. McAfee

       

    Chair and Chief Executive Officer

     

    POWER OF ATTORNEY

     

    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Eric A. McAfee and Todd Waltz, and each of them, as their true and lawful attorneys-in-fact and agents with full power of substitution and re-substitution, for their and in their name, place and stead, in any and all capacities, to sign this Form S-8 Registration Statement and any amendments (including post-effective amendments) to this Form S-8 Registration Statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as they might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed below by the following persons in the capacities and on the date indicated. 

     

    Name

     

    Title

    Date

           

    /s/ Eric A. McAfee

     

    Chair of the Board and Chief Executive Officer

    March 13, 2026

    Eric A. McAfee

     

    (Principal Executive Officer and Director)

     
           

    /s/ Todd A. Waltz

     

    Chief Financial Officer

    March 13, 2026

    Todd A. Waltz

     

    (Principal Financial Officer)

     
           

    /s/ Francis P. Barton

     

    Director

    March 13, 2026

    Francis P. Barton

         
           

    /s/ Lydia I. Beebe

     

    Director

    March 13, 2026

    Lydia I. Beebe

         
           

    /s/ John R. Block

     

    Director

    March 13, 2026

    John R. Block

         
           

    /s/ Naomi L. Boness

     

    Director

    March 13, 2026

    Naomi L. Boness

         
           

    /s/ Timothy A. Simon

     

    Director

    March 13, 2026

    Timothy A. Simon

         

     

     
    Get the next $AMTX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMTX

    DatePrice TargetRatingAnalyst
    8/16/2023$2.50 → $10.50Neutral → Buy
    UBS
    2/28/2023$3.00Underweight
    Piper Sandler
    12/14/2022$4.25Neutral
    UBS
    8/9/2022$12.00Buy → Hold
    Truist
    11/22/2021$31.00 → $35.00Outperform
    Credit Suisse
    8/23/2021$40.00 → $31.00Outperform
    Credit Suisse
    7/15/2021$25.00Outperform
    Evercore ISI Group
    More analyst ratings

    $AMTX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aemetis Reports Fourth Quarter and Full Year 2025 Results as Dairy RNG Platform Scales

    Dairy RNG production increased 61% year over year in Q4 2025; ethanol plant efficiency upgrade expected to increase plant cash flow from operations by approximately $32 million annually Aemetis Biogas segment net income increased to $12.2 million in Q4 2025Aemetis Biogas segment increased annual revenues and production tax credits by 53%Dairy RNG production increased 61% year over year in Q4 2025Aemetis Biogas achieved annual segment net income of $6.9 millionCapital investments increased 28% over the prior year to $26.0 million, supporting dairy RNG expansion and ethanol plant energy efficiency upgradesDairy digester projects generated cash proceeds of $18 million during 2025 from the sale

    3/12/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis to Review Fourth Quarter and Year End 2025 Financial Results on March 12, 2026

    CUPERTINO, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX) announced that the company will host a conference call to review the release of its fourth quarter and year end 2025 earnings report: Date: Thursday, March 12, 2026 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 452750 Live Participant Dial In (International): +1-973-528-0011 entry code 452750 Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/53629 Attendees may submit questions during the Q&A (Questions & Answers) portion of the conference call. The webcast will be available on the Company's website (www.aemetis.com) under Investors/Conference Cal

    3/6/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis India Subsidiary Begins Biodiesel Deliveries Under $24 Million Allocation from OMCs

    CUPERTINO, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX), a diversified renewable natural gas and biofuels company, announced that its Universal Biofuels subsidiary in India secured allocations of approximately $24 million for the supply of more than 27 million liters of biodiesel to India's three government-owned Oil Marketing Companies (OMCs) for the period ending March 2026. Additional OMC fuel supply orders are expected throughout the year to support the India government's goal of increasing from a 1% biodiesel blend to a targeted 5%, as stated in the current India National Policy on Biofuels. "Universal Biofuels and other biodiesel producers look forward to c

    2/3/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    SEC Filings

    View All

    Aemetis Inc. (DE) filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K - AEMETIS, INC (0000738214) (Filer)

    3/16/26 4:18:27 PM ET
    $AMTX
    Major Chemicals
    Industrials

    SEC Form S-8 filed by Aemetis Inc. (DE)

    S-8 - AEMETIS, INC (0000738214) (Filer)

    3/16/26 8:12:32 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis Inc. (DE) filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - AEMETIS, INC (0000738214) (Filer)

    3/12/26 8:30:09 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Simon Timothy Alan was granted 12,000 shares, increasing direct ownership by 30% to 52,632 units (SEC Form 4)

    4 - AEMETIS, INC (0000738214) (Issuer)

    1/28/26 8:08:09 PM ET
    $AMTX
    Major Chemicals
    Industrials

    Director Block John R was granted 12,000 shares, increasing direct ownership by 35% to 46,330 units (SEC Form 4)

    4 - AEMETIS, INC (0000738214) (Issuer)

    1/28/26 8:07:34 PM ET
    $AMTX
    Major Chemicals
    Industrials

    Director Barton Francis P was granted 18,000 shares, increasing direct ownership by 9% to 226,518 units (SEC Form 4)

    4 - AEMETIS, INC (0000738214) (Issuer)

    1/28/26 8:06:59 PM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Aemetis upgraded by UBS with a new price target

    UBS upgraded Aemetis from Neutral to Buy and set a new price target of $10.50 from $2.50 previously

    8/16/23 8:55:59 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Piper Sandler initiated coverage on Aemetis with a new price target

    Piper Sandler initiated coverage of Aemetis with a rating of Underweight and set a new price target of $3.00

    2/28/23 6:17:45 AM ET
    $AMTX
    Major Chemicals
    Industrials

    UBS initiated coverage on Aemetis with a new price target

    UBS initiated coverage of Aemetis with a rating of Neutral and set a new price target of $4.25

    12/14/22 7:31:59 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Financials

    Live finance-specific insights

    View All

    Aemetis Reports Fourth Quarter and Full Year 2025 Results as Dairy RNG Platform Scales

    Dairy RNG production increased 61% year over year in Q4 2025; ethanol plant efficiency upgrade expected to increase plant cash flow from operations by approximately $32 million annually Aemetis Biogas segment net income increased to $12.2 million in Q4 2025Aemetis Biogas segment increased annual revenues and production tax credits by 53%Dairy RNG production increased 61% year over year in Q4 2025Aemetis Biogas achieved annual segment net income of $6.9 millionCapital investments increased 28% over the prior year to $26.0 million, supporting dairy RNG expansion and ethanol plant energy efficiency upgradesDairy digester projects generated cash proceeds of $18 million during 2025 from the sale

    3/12/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis to Review Fourth Quarter and Year End 2025 Financial Results on March 12, 2026

    CUPERTINO, Calif., March 06, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX) announced that the company will host a conference call to review the release of its fourth quarter and year end 2025 earnings report: Date: Thursday, March 12, 2026 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 452750 Live Participant Dial In (International): +1-973-528-0011 entry code 452750 Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/53629 Attendees may submit questions during the Q&A (Questions & Answers) portion of the conference call. The webcast will be available on the Company's website (www.aemetis.com) under Investors/Conference Cal

    3/6/26 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis to Review Third Quarter 2025 Financial Results on November 6, 2025

    CUPERTINO, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ:AMTX) announced that the company will host a conference call to review the release of its third quarter 2025 earnings report: Date: Thursday, November 6, 2025 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 188767  Live Participant Dial In (International): +1-973-528-0011 entry code 188767 Webcast URL: https://www.webcaster5.com/Webcast/Page/2211/53150 Attendees may submit questions during the Q&A (Questions & Answers) portion of the conference call. The webcast will be available on the Company's website (www.aemetis.com) under Investors/Conference Calls, along w

    10/31/25 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    $AMTX
    Leadership Updates

    Live Leadership Updates

    View All

    Aemetis Appoints J. Michael Rockett as Executive Vice President, General Counsel and Corporate Secretary

    CUPERTINO, Calif., Aug. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aemetis, Inc. (NASDAQ:AMTX), a renewable natural gas and renewable fuels company focused on negative carbon intensity products, has appointed J. Michael Rockett as Executive Vice President, General Counsel and Corporate Secretary, effective immediately. Mr. Rockett brings over 28 years of relevant experience to the company. Prior to joining Aemetis, he was Vice President, General Counsel, and Corporate Secretary of InEnTec Inc., a developer of technology and facilities to convert waste into renewable fuels and chemical products. Mr. Rockett was formerly an attorney at the law firm of Pillsbury Winthrop Shaw Pittman L

    8/28/23 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Aemetis Appoints Former California Public Utilities Commissioner Timothy Simon to the Aemetis Board of Directors

    CUPERTINO, CA, Oct. 18, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Aemetis, Inc. (NASDAQ:AMTX), a renewable natural gas (RNG) and renewable fuels company focused on negative carbon intensity products, today announced the appointment of Timothy Alan Simon, Esq., former Commissioner of the California Public Utilities Commission (CPUC), to the Company's Board of Directors, effective October 14.  Mr. Simon was appointed to the CPUC by Governor Arnold Schwarzenegger in February 2007, ending his term in December 2012. During his time as a CPUC commissioner, Mr. Simon served as Chair of the National Association of Regulatory Utility Commissioners ("NARUC") Natural Gas Committee; Chair of the

    10/18/21 8:00:00 AM ET
    $AMTX
    Major Chemicals
    Industrials

    Indonesia Energy Corporation Announces Appointment of Michael L. Peterson to Board of Directors

    Experienced energy industry and finance executive to serve as Chairman of IEC's Audit Committee JAKARTA, INDONESIA AND DANVILLE, CA / ACCESSWIRE / January 25, 2021 / Indonesia Energy Corporation (NYSE American:INDO) ("IEC"), an oil and gas exploration and production company focused on Indonesia, today announced that the company's Board of Directors has appointed Michael L. Peterson to the Board. Mr. Peterson will serve as an independent Board member and will also serve as the Chairman of the Audit Committee of the Board of Directors. Mr. Peterson has over 30 years of experience in executive management positions in all aspects of the energy industry and finance industries, having served as

    1/25/21 9:00:00 AM ET
    $PED
    $MEDS
    $INDO
    Oil & Gas Production
    Energy
    Other Pharmaceuticals
    Health Care

    $AMTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Aemetis Inc. (DE) (Amendment)

    SC 13G/A - AEMETIS, INC (0000738214) (Subject)

    2/14/24 4:19:02 PM ET
    $AMTX
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Aemetis Inc. (DE) (Amendment)

    SC 13G/A - AEMETIS, INC (0000738214) (Subject)

    2/14/24 2:54:17 PM ET
    $AMTX
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by Aemetis Inc. (DE) (Amendment)

    SC 13G/A - AEMETIS, INC (0000738214) (Subject)

    2/13/24 6:50:28 AM ET
    $AMTX
    Major Chemicals
    Industrials